0
  • Notifications
  • No notifications yet

  • View All Notifications
ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Biocomposites Launches Two New Phase Ii Trials
News Feed
course image
  • 09 Feb 2024
  • Admin
  • News Article

Biocomposites launches two new phase II trials

Biocomposites launches two new phase II trials of Stimulan VG mixed with vancomycin and gentamicin in US

Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, announces the launch of two phase II clinical trials of Stimulan VG in the US.

Both trials are part of an investigational new drug (IND) application that will evaluate the safety and efficacy of Stimulan VG (Stimulan mixed with vancomycin and gentamicin).

Biocomposites is now recruiting patients to its BLADE-VG2 trial, which will evaluate the safety and efficacy of Stimulan VG in treating diabetic foot osteomyelitis. In addition, Biocomposites will shortly be commencing its BLADE-OPU2 trial, which will investigate the safety and efficacy of Stimulan VG in treating stage IV pressure ulcers.

With over 500K diabetic foot osteomyelitis and 200K stage IV pressure ulcer cases in the US every year, the need to transform patient outcomes in these areas and minimise the use of systemic antibiotics has never been more important.

Michael Harris, chief executive officer said: “The Stimulan VG trials are an important next step in our mission to be the ‘go to’ provider for surgeons seeking products to help them in their infection management cases. Diabetic foot osteomyelitis and stage IV pressure ulcers can severely impact a patient’s quality of life and are a burden to healthcare systems. These trials aim to demonstrate the potential for Stimulan VG to transform patient outcomes, minimise use of antibiotics and save healthcare systems significant sums of money by reducing the incidence of recurrent infection.”

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form